 Treatment systemic sporotrichosis ketoconazole Infections deep soft tissues dimorphic fungus Sporothrix schenckii uncommon humans therapy toxic drugs experience patients deep-seated sporotrichosis ketoconazole well-tolerated absorbed antifungal agent Eight infections joints thoracic cervical widespread cutaneous sites patients evidence infection therapy remissions months years patients discontinuation therapy additional patient years initiation ketoconazole treatment Durable responses prolonged treatment mg ketoconazole daily favorable experience oral therapy ketoconazole patients systemic sporotrichosis